This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define residual tumor deposits after combination chemo/radiotherapy. Finally, the childhood malignancies that still have a poor prognosis are presented, and new novel ways of therapy are explained.
Lieferbar
ISBN | 9780849367526 |
---|---|
Sprache | eng |
Cover | Fester Einband |
Verlag | Taylor and Francis |
Jahr | 19890531 |
Dieser Artikel hat noch keine Bewertungen.